|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期1989-01-01 |
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Premature Ejaculation.
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Premature Ejaculation.
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Premature Ejaculation.
100 项与 Biovail Laboratories International SRL 相关的临床结果
0 项与 Biovail Laboratories International SRL 相关的专利(医药)
100 项与 Biovail Laboratories International SRL 相关的药物交易
100 项与 Biovail Laboratories International SRL 相关的转化医学